New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
09:18 EDTIMRS, CSIQ, YONG, XOMA, AVAV, VEEV, NAVB, SWHC, NLSN, THRM, USUOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Smith & Wesson (SWHC), up 10%... AeroVironment (AVAV), up 7%... Gentherm (THRM), up 4%... Veeva (VEEV), up 5%. ALSO HIGHER: Dara (DARA), up 19% after signing agreement with WellCare (WCG) for Soltamox formulary status... Navidea (NAVB), up 3.7% after announcing FDA accepts sNDA to further expand Lymphoseek labeling. DOWN AFTER EARNINGS: Canadian Solar (CSIQ), down 5.4%... IMRIS (IMRS), down 3%. ALSO LOWER: XOMA (XOMA), down 21% after Phase II trial failure of gevokizumab in Erosive Osteoarthritis of the Hand... USEC (USU), down 29% after implementing financial restructuring plan under Chapter 11... Yongye (YONG), down 13% after announcing going private proposal not approved by stockholders...Nielsen (NLSN), down 2% after 30M share spot secondary offering of stock priced at $46.45.
News For SWHC;XOMA;USU;NAVB;YONG;THRM;VEEV;CSIQ;NLSN;AVAV;IMRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 25, 2014
16:08 EDTVEEVVeeva sees FY14 non-GAAP EPS 33c-34c, consensus 31c
Subscribe for More Information
16:07 EDTVEEVVeeva sees Q4 non-GAAP EPS 8c-9c, consensus 7c
Sees Q4 revenue $84.5M-$85.5M, consensus $81.62M.
16:06 EDTVEEVVeeva reports Q3 non-GAAP EPS 7c, consensus 8c
Subscribe for More Information
15:31 EDTVEEVNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Hewlett-Packard (HPQ), consensus $1.06; Analog Devices (ADI), consensus 68c; Cubic (CUB), consensus 94c; Nimble Storage (NMBL), consensus (16c); Veeva Systems (VEEV), consensus 8c; Infoblox (BLOX), consensus 3c; TiVo (TIVO), consensus 7c; Perfect World (PWRD), consensus 40c.
14:29 EDTVEEVVeeva technical comments ahead of results
The shares for the last several months have been trading largely within the range of $25 at the low and $30 at the high. Those two bounds and how price behaves around them may give us important information about post-earnings price reactions. Currently the stock is trading close to the upper end of the range. If the news is positive, a run to $30 would appear to be highly probable. A breakout above $30 would resolve the current trading range bullishly. Next resistance levels as potential upside objectives would be at $31.56 and then at $33.47. If the news is a disappointment, it is probable that the low of the range would be tested. On the way to such a test an intermediate support level would be at $27.44. A test of $25 that does not break it would leave the shares range bound. On an extreme move, support below $25 would be at $23.68.
November 24, 2014
10:01 EDTSWHCSmith & Wesson, General Dynamics partner on modular handgun system
Subscribe for More Information
07:33 EDTCSIQDominion acquires solar facility in California from Canadian Solar
Subscribe for More Information
November 21, 2014
06:28 EDTCSIQNRG Energy to seek large cuts in carbon emissions
Subscribe for More Information
November 20, 2014
10:02 EDTAVAVOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:31 EDTNAVBNavidea granted marketing authorization for Lymphoseek by European Commission
Navidea Biopharmaceuticals has announced that the European Commission has granted marketing authorization for Lymphoseek 250 micrograms kit for radiopharmaceutical preparation. Lymphoseek is now approved in the European Union for use in imaging and intraoperative detection of sentinel lymph nodes draining a primary tumor in adult patients with breast cancer, melanoma, or localized squamous cell carcinoma of the oral cavity. The sentinel node detection label in Europe may now allow Lymphoseek to be used in approximately 367,000, 83,000 and 55,000 new cases of breast cancer, melanoma and oral cavity cancers diagnosed in Europe annually, respectively. Lymphoseek is approved in the U.S. for use in lymphatic mapping to locate lymph nodes draining a primary tumor site in patients with solid tumors for which this procedure is a component of intraoperative management and for guiding Sentinel Lymph Node Biopsy using a handheld gamma counter in patients with node negative squamous cell carcinoma of the oral cavity, breast cancer or melanoma.
07:13 EDTIMRSCanaccord to hold a forum
Subscribe for More Information
07:03 EDTAVAVAeroVironment initiated with a Hold at Canaccord
Subscribe for More Information
06:28 EDTNLSNBillboard 200 chart to include on-demand streaming in rankings
The Billboard 200 albums chart will premiere its biggest upgrade in more than 23 years, transforming from a pure sales-based ranking to one measuring multi-metric consumption. Beginning with the top 10 revealed on Wednesday, Dec. 3, on Billboard.com, the chart, which currently tracks the top 200 albums of the week by sales alone, will be the first to include on-demand streaming and digital track sales -- as measured by Nielsen Entertainment (NLSN) -- by way of a new algorithm. It is the most substantial methodology update since May 1991, when Billboard first used Nielsen's point-of-sale data -- SoundScan -- to measure album sales. The updated Billboard 200 will utilize accepted industry benchmarks for digital and streaming data, equating 10 digital track sales from an album to one equivalent album sale, and 1,500 song streams from an album to one equivalent album sale. All of the major on-demand audio subscription services are considered, including Spotify, Beats Music (AAPL), Google Play (GOOG) and Xbox Music (MSFT). Reference Link
November 19, 2014
12:43 EDTNLSNRentrak weakness on Nielsen news misplaced, says Brean Capital
Subscribe for More Information
06:34 EDTNLSNNielsen to begin measuring viewing of subscription video services, WSJ reports
Subscribe for More Information
November 18, 2014
12:59 EDTCSIQChinese solars advance following JA Solar results
Subscribe for More Information
11:18 EDTCSIQCanadian Solar initiated with a Buy at Standpoint Research
Target $36.
10:20 EDTCSIQOptions with decreasing implied volatility
Subscribe for More Information
07:02 EDTCSIQCanadian Solar modules to power series of projects in Georgia totaling 5.1 MW
Subscribe for More Information
November 17, 2014
07:06 EDTCSIQCanadian Solar achieves PV module qualification with Sunrun
Canadian Solar announced that Sunrun, one of the largest dedicated residential solar companies in the United States, approved Canadian Solar as its qualified vendor.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use